B. Altman
Molecular Biology · 2015–2016
A researcher in the Science corpus: 3 papers; trusts 5 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 99 citations into it; #12,470 of 17,773 by trust here, #9,136 by citations
- Cancer Research — 71 citations into it; #1,052 of 1,780 by trust here, #1,074 by citations
- Genetics — 9 citations into it
Whom B. Altman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts B. Altman overall
Papers from B. Altman's perspective
Ordered by how strongly the researchers B. Altman trusts endorse each paper. Same corpus, a different order for every researcher.
- c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism (Nature)
- Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis (Molecular and Cellular Biology)
- Targeting mitochondrial glutaminase activity inhibits oncogenic transformation (Cancer Cell)
- Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* (Journal of Biological Chemistry)
- mTOR signaling in growth control and disease (Cell)
- Glutamine and cancer: cell biology, physiology, and clinical opportunities. (Journal of Clinical Investigation)
- Acetate is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases (Cell)
- HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. (Cancer Cell)
- Acetate Dependence of Tumors (Cell)
- Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- MYC, Metabolism, and Cancer. (2015) — 1,111 citations
- From Krebs to clinic: glutamine metabolism to cancer therapy (2016) — 823 citations
- From Krebs to Clinic: Glutamine Metabolism to Cancer Therapy (2016) — 1,349 citations